SEC 13F Intelligence

Boxer Capital, LLC / RCKT

Boxer Capital, LLC’s Rocket Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Rocket Pharmaceuticals Inc (RCKT)? Not currently — the last reported position was 1.47M shares worth $27M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$27M
Q3 2024
Shares
1.47M
% of Portfolio
+1.33%
Quarters Held
24
position exited

Position History RCKT

Reported value by quarter
Q4 ’18: $29MQ4 ’18Q1 ’19: $26MQ2 ’19: $22MQ3 ’19: $17MQ3 ’19Q4 ’19: $33MQ1 ’20: $20MQ2 ’20: $31MQ2 ’20Q3 ’20: $34MQ4 ’20: $80MQ1 ’21: $65MQ1 ’21Q2 ’21: $65MQ3 ’21: $44MQ4 ’21: $32MQ4 ’21Q1 ’22: $23MQ2 ’22: $20MQ3 ’22: $23MQ3 ’22Q4 ’22: $29MQ1 ’23: $25,113Q2 ’23: $29,130Q2 ’23Q3 ’23: $30MQ4 ’23: $44MQ1 ’24: $39MQ1 ’24Q2 ’24: $32MQ3 ’24: $27Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.47M$27M+1.33%
Q2 20241.47M$32M+1.66%
Q1 20241.47M$39M+1.95%
Q4 20231.47M$44M+2.19%
Q3 20231.47M$30M+1.60%
Q2 20231.47M$29,130+1.35%
Q1 20231.47M$25,113+1.23%
Q4 20221.47M$29M+1.51%
Q3 20221.47M$23M+1.32%
Q2 20221.47M$20M+1.28%
Q1 20221.47M$23M+1.20%
Q4 20211.47M$32M+1.24%
Q3 20211.47M$44M+1.53%
Q2 20211.47M$65M+2.29%
Q1 20211.47M$65M+2.21%
Q4 20201.47M$80M+2.58%
Q3 20201.47M$34M+1.16%
Q2 20201.47M$31M+1.35%
Q1 20201.47M$20M+1.39%
Q4 20191.47M$33M+1.89%
Q3 20191.47M$17M+1.24%
Q2 20191.47M$22M+1.89%
Q1 20191.47M$26M+2.97%
Q4 20181.97M$29M+3.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of RCKT.